Skip to Main Content

Paper Details

Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors.
Nat Commun
232
2017
CRC, Colorectal carcinoma, EGFR, RAF, RAS, cetuximab, colorectal cancer, human, organoids, patient, patients, tumours
Author NameAffiliation
Thomas RischMax Planck Institute for Molecular Genetics
Vyacheslav AmstislavskiyMax Planck Institute for Molecular Genetics
Hans-J??rg WarnatzMax Planck Institute for Molecular Genetics
Ralf HerwigMax Planck Institute for Molecular Genetics
Mats NilssonUppsala University
Mats NilssonStockholm University
Mats NilssonUppsala University
Mats NilssonStockholm University
Christoph ReinhardLilly Research Laboratories
Christoph ReinhardLilly Research Laboratories
Stephan BeckUCL Cancer Institute, University College London
Johannes HaybaeckInstitute of Pathology, Medical University of Graz
Johannes HaybaeckCenter for Biomarker Research in Medicine
Marie-Laure YaspoMax Planck Institute for Molecular Genetics
  • 1 - 14

Datasets

Release 1.2